Ground Glass Opacities Observed in a 26-Year-Old Coronavirus Disease 2019 (COVID-19) Rule-Out Patient With a History of Vape Use

Patel, Vivek N; Rouse, Michael J.; Brown, Christopher L.; Pandya, S.

doi:10.7759/cureus.10302

Cited by 3 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has been reported very recently that pulmonary imaging findings from e-cigarette users, EVALI, and COVID-19 may be similar [44]. Though COVID-19 and EVALI have related characteristic CT manifestations that mostly can be differentiated in their classic forms, when presented with overlapping imaging features, the distinction is of great importance, which might be hard due to symptoms common in both disorders such as shortness of breath, cough, fever and gastrointestinal symptoms [43].…”

Section: Vaping-induced Lung Injury (Evali) and Covid-19mentioning

confidence: 99%

COVID-19 and the role of e-cigarette use: An evidence-based review

Çok¹,

Iyigündoğdu²,

Yıldırım³

2021

jrp

View full text Add to dashboard Cite

While the world is grappling with one of the biggest pandemics in history, the role that personal preferences or lifestyles can play in the development of this pandemic should not be overlooked. One of these preferences is the use of electronic cigarettes (e-cigarettes). COVID-19 is a disease that primarily attacks the lungs. Thus, factors that cause pre-existing lung disease such as e-cigarette use may increase the risk for critical complications from COVID-19. Promoted as an alternative to conventional cigarettes, e-cigarettes induce inflammation of human airways and possibly increase susceptibility toward pneumonia because of an increase of pneumococcal adherence to airway cells. Lung damage caused by flavorings contained in e-cigarettes can increase health risks, especially from COVID-19. When compared to nonsmokers, e-cigarette users had a five times increased risk while dual users with tobacco had a seven times increased risk of COVID-19 infection. Recent research supports that many medical consequences such as lung inflammation and increased susceptibility to pulmonary viral and bacterial infections in smokers and people with COVID-19 disease may also develop due to e-cigarette use. The aim of this article is to investigate whether there is a role for e-cigarette use in the development of respiratory diseases caused by the COVID-19 virus. With the help of our experience of working on e-cigarettes for many years and various scientific databases (PubMed, Scopus, etc.), the health risks experienced by people who both use e-cigarettes and have a COVID-19 virus infection, and the role of respiratory system symptoms, in particular, were investigated.

show abstract

Section: Vaping-induced Lung Injury (Evali) and Covid-19mentioning

confidence: 99%

COVID-19 and the role of e-cigarette use: An evidence-based review

Çok¹,

Iyigündoğdu²,

Yıldırım³

2021

jrp

View full text Add to dashboard Cite

show abstract

E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

Marrocco

Singh

Christiani

et al. 2022

Critical Reviews in Toxicology

View full text Add to dashboard Cite

The Complexity in the Diagnosis and Treatment of Symptoms in Electronic Cigarette Users during the COVID-19 Pandemic

Ahmed

2022

Pharmacoepidemiology

View full text Add to dashboard Cite

The issue with the overlapping clinical symptoms from an electronic cigarette (e-cigarette) or vaping product use-associated lung injury (EVALI) and coronavirus disease 2019 (COVID-19) sometimes leads to incorrect diagnosis and, consequently, wrong treatment regimen. The purpose of this review is to study the burden of vaping-associated health consequences on the diagnosis and treatment of COVID-19 in young adults and adolescents with a misconception of e-cigarettes as a safer alternative to smoking. The online reference databases, including PubMed, Google Scholar, Web of Science, Medline, and Centers for Disease Control and Prevention (CDC), were used in the literature search, as we analyzed the complexity of timely diagnosis and treatment in the current COVID-19 era with the use of e-cigarettes. This study briefly describes the dysbiosis of the oral microbiome in e-cigarette users that could potentially aggravate the COVID-19 symptoms and lead to the complexity of timely diagnosis and treatment. Additionally, the patient case reports with a history of vaping and symptoms similar to COVID-19 disease are reviewed.

show abstract

Ground Glass Opacities Observed in a 26-Year-Old Coronavirus Disease 2019 (COVID-19) Rule-Out Patient With a History of Vape Use

Cited by 3 publications

References 2 publications

COVID-19 and the role of e-cigarette use: An evidence-based review

COVID-19 and the role of e-cigarette use: An evidence-based review

E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs

The Complexity in the Diagnosis and Treatment of Symptoms in Electronic Cigarette Users during the COVID-19 Pandemic

Contact Info

Product

Resources

About